Mesoblast (MESO) Net Margin (2016 - 2023)

Mesoblast's (MESO) quarterly Net Margin came in at 771.54% in Q2 2023, up 282961.0% year-on-year from N/an in Q2 2022, and up 124.95% quarter-over-quarter from 3092.83% in Q1 2023.

Mesoblast (MESO) Net Margin (2016 - 2023) Analysis & Trends

Mesoblast has disclosed Net Margin across 8 years of filings, most recently posting 771.54% for Q2 2023.

  • Net Margin for Q2 2023 came in at 771.54%, up 282961.0% year-over-year; the trailing twelve-month figure through Mar 2023 was 1395.98% (down 80412.0% YoY), and the FY2025 annual result was 593.92%, changed N/A from the prior year.
  • Net Margin came in at 771.54% for Q2 2023 at Mesoblast, up from 3092.83% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 2396.35% in Q1 2019 to a low of 3845.24% in Q2 2021.
  • The 5-year median for Net Margin is 280.33% (2020), against an average of 329.09%.
  • Across the five-year window, Net Margin jumped 385508 bps in 2019 and slumped 415211 bps in 2023, its largest moves.
  • Mesoblast's Net Margin stood at 1248.55% in 2019, then dropped by 8 bps to 1146.45% in 2020, then declined by 5 bps to 1089.21% in 2021, then gained by 14 bps to 1236.67% in 2022, then tumbled by 38 bps to 771.54% in 2023.
  • The last three Net Margin figures came in at 771.54% (Q2 2023), 3092.83% (Q1 2023), and 1236.67% (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.82%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 34.53%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Mesoblast 21.68 Bn 21.55 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2023 771.54%
Mar 31, 2023 -3,092.83%
Dec 31, 2022 1,236.67%
Sep 30, 2022 -1,170.06%
Jun 30, 2022 -2,058.07%
Mar 31, 2022 1,059.27%
Dec 31, 2021 1,089.21%
Sep 30, 2021 -934.97%
Jun 30, 2021 -3,845.24%
Mar 31, 2021 1,354.19%
Dec 31, 2020 1,146.45%
Sep 30, 2020 -1,880.77%
Jun 30, 2020 -172.79%
Mar 31, 2020 733.45%
Dec 31, 2019 1,248.55%
Sep 30, 2019 -292.95%
Jun 30, 2019 -3,511.59%
Mar 31, 2019 2,396.35%
Dec 31, 2018 2,021.69%
Sep 30, 2018 -1,938.17%